文献速递类风湿关节炎

血浆微生物tDR-1升高与高危个体免于临床类风湿关节炎相关

Increased Plasma Microbial tDR-1 in At-Risk Individuals Is Associated With Decreased Conversion to Clinical Rheumatoid Arthritis and Reduces an In Vitro Macrophage Type 1 Interferon Response.
PubMed 文献 · Arthritis Rheumatol · 2026-06-22

在60例抗CCP3阳性高危个体中,基线血浆微生物tDR-1浓度在未转化者中较转化者高5.4倍,调整共享表位、吸烟和类风湿因子后仍显著(P=5.1×10⁻⁴);加入tDR-1后AUROC从0.722升至0.902(P=0.003)。体外实验显示tDR-1下调THP-1巨噬细胞多个1型干扰素应答基因。

要点

  • CCP3阳性高危个体中,较高血浆tDR-1与未转化为临床RA相关。
  • tDR-1可提升传统危险因素对RA转化的判别能力(AUROC 0.722→0.902)。
  • tDR-1体外下调巨噬细胞1型干扰素应答基因,提示潜在机制。

核心结论

  • 在CCP3阳性高危个体中,较高血浆tDR-1浓度与未转化为临床RA相关。
  • tDR-1降低1型干扰素应答基因表达,可能解释微生物影响RA发展的机制。

研究设计与样本

  • 研究纳入60例CCP3阳性高危个体,测量血浆tDR-1浓度并随访转化状态。
  • 采用lognormal Welch t检验和逻辑回归比较组间差异,AUROC评估判别能力。
  • 体外用tDR-1与 scramble 对照处理人THP-1单核细胞来源巨噬细胞,NanoString免疫panel检测基因表达。

主要发现

  • 60例中25例 later 转化为临床RA(转化者),平均随访2.2年;35例未转化,平均随访5.3年。
  • 基线血浆tDR-1浓度在未转化者中较转化者高5.4倍,调整共享表位、吸烟和类风湿因子后P=5.1×10⁻⁴。
  • 仅用上述危险因素AUROC为0.722,加入tDR-1后升至0.902(P=0.003)。
  • 体外tDR-1显著下调THP-1细胞中多个1型干扰素应答基因。

关键数值与推荐

  • CCP3阳性高危个体中,未转化者基线血浆tDR-1较转化者高5.4倍(P=5.1×10⁻⁴)。
  • 加入tDR-1后AUROC从0.722提高至0.902(P=0.003)。

临床怎么用

  • 血浆tDR-1或可作为CCP3阳性高危个体RA转化的潜在生物标志物,尚需外部验证。
  • tDR-1下调1型干扰素应答的发现提示微生物小RNA可能参与RA发病调控。

局限性

  • 样本量60例,转化者25例,结果需更大队列验证。
  • 体外机制研究使用THP-1细胞系,与人体内环境存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Microbial small RNAs can regulate human genes. Higher plasma concentrations of microbial transfer RNA (tRNA)-derived RNA-1 (tDR-1) were previously associated with lower rheumatoid arthritis (RA) disease activity. This study examined whether tDR-1 concentrations differ in anticyclic citrullinated peptide-3 positive (CCP3+) at-risk individuals (ARI), based on who later develops clinical RA, or discriminate later conversion status beyond established risk factors and if tDR-1 has in vitro effects. METHODS: Plasma tDR-1 concentrations were measured in CCP3+ ARI. Group differences in log-transformed tDR-1 were assessed by lognormal Welch's t-test and logistic regression. Area under the receiver operating characteristic curve (AUROC) was used to evaluate discriminatory ability. Human THP-1 monocyte-derived macrophages were treated with tDR-1 versus scramble control, and gene expression was assessed by NanoString Immunology panel. RESULTS: Among 60 CCP3+ ARI, 25 later developed clinical RA ("converters") over a mean of 2.2 years, whereas 35 did not ("nonconverters") over a mean of 5.3 years. Baseline plasma tDR-1 concentrations were significantly higher (5.4-fold) in nonconverters versus converters, even after adjustment for additional RA risk factors (shared epitope, smoking, rheumatoid factor) (P = 5.1 × 10-4). The AUROC improved from 0.722 for these risk factors alone to 0.902 with the addition of tDR-1 (P = 0.003). In vitro, tDR-1 significantly down-regulated many type 1 interferon (IFN) response genes in THP-1 cells. CONCLUSION: Higher plasma tDR-1 concentrations were associated with nonconversion to clinical RA in CCP3+ ARI. tDR-1's reducing type 1 IFN response gene expression suggests a potential mechanism by which microbes and tDR-1 could affect RA development.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Phothisane A, Joishy TK, Ramirez-Becerra C, et al. Increased Plasma Microbial tDR-1 in At-Risk Individuals Is Associated With Decreased Conversion to Clinical Rheumatoid Arthritis and Reduces an In Vitro Macrophage Type 1 Interferon Response. Arthritis Rheumatol. 2026. PMID: 42332992. doi:10.1002/art.70264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。